AR092719A1 - METHOD AND COMPOSITION FOR THE TREATMENT OF ECTOPARASITES - Google Patents

METHOD AND COMPOSITION FOR THE TREATMENT OF ECTOPARASITES

Info

Publication number
AR092719A1
AR092719A1 ARP130103492A ARP130103492A AR092719A1 AR 092719 A1 AR092719 A1 AR 092719A1 AR P130103492 A ARP130103492 A AR P130103492A AR P130103492 A ARP130103492 A AR P130103492A AR 092719 A1 AR092719 A1 AR 092719A1
Authority
AR
Argentina
Prior art keywords
animal
spinosyne
treatment
composition
ectoparasites
Prior art date
Application number
ARP130103492A
Other languages
Spanish (es)
Inventor
Al Alawi Fadil
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of AR092719A1 publication Critical patent/AR092719A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Abstract

Método de tratamiento de un animal infestado con piojos mordedores caracterizado por el paso de administrar internamente al animal una cantidad farmacéuticamente eficaz de -al menos- una espinosina, de modo tal que la espinosina esté presente sistémicamente dentro del animal. Reivindicación 11: Una composición para la administración interna a un animal, que incluye una espinosina en el orden de 0,1% a 65% p/v. Reivindicación 12: Un régimen de dosificación para el tratamiento de piojos mordedores en un animal, caracterizado por el paso de administrar una espinosina internamente con una dosis igual a -o menor que- 40 miligramos por kilogramo del animal.Method of treating an animal infested with biting lice characterized by the step of internally administering to the animal a pharmaceutically effective amount of -at least- a spinosyne, such that spinosyne is present systemically within the animal. Claim 11: A composition for internal administration to an animal, which includes a spinosyne in the order of 0.1% to 65% w / v. Claim 12: A dosage regimen for the treatment of biting lice in an animal, characterized by the step of administering a spinosyne internally with a dose equal to -or less than- 40 milligrams per kilogram of the animal.

ARP130103492A 2012-09-28 2013-09-27 METHOD AND COMPOSITION FOR THE TREATMENT OF ECTOPARASITES AR092719A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ60272312 2012-09-28

Publications (1)

Publication Number Publication Date
AR092719A1 true AR092719A1 (en) 2015-04-29

Family

ID=50388697

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103492A AR092719A1 (en) 2012-09-28 2013-09-27 METHOD AND COMPOSITION FOR THE TREATMENT OF ECTOPARASITES

Country Status (5)

Country Link
AR (1) AR092719A1 (en)
AU (2) AU2012233000B2 (en)
UY (1) UY35059A (en)
WO (1) WO2014051440A1 (en)
ZA (1) ZA201502205B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2557986C1 (en) * 2014-07-31 2015-07-27 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт ветеринарной энтомологии и арахнологии" (ФГБНУ ВНИИВЭА) Method for protection of cattle from ixodic ticks
BR112022010049A2 (en) 2019-12-16 2022-08-16 Intervet Int Bv PARASITE CONTROL IN RUMINANTS
EP4075981A1 (en) 2019-12-16 2022-10-26 Intervet International B.V. Composition for lice control

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591606A (en) * 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
CA2156194C (en) * 1993-03-12 2008-01-08 Jon S. Mynderse New a83543 compounds and process for production thereof

Also Published As

Publication number Publication date
AU2016202546A1 (en) 2016-05-19
ZA201502205B (en) 2017-11-29
UY35059A (en) 2014-03-31
AU2012233000B2 (en) 2016-01-21
WO2014051440A1 (en) 2014-04-03
AU2012233000A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
NZ604029A (en) Methods of treating bladder cancer
BR112015023922A2 (en) pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of using these
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
CR11724A (en) AGENT TO TREAT DISEASES
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
CO6251212A2 (en) THERAPEUTIC TREATMENT OF METABOLIC SYNDROME DIABETES TYPE 2 OBESITY OR PREDIABETES
EA201690738A1 (en) DRY POWDER INHALER
CR11723A (en) AGENT TO TREAT DISEASE
CO2018009561A2 (en) Methods for treating depression with orexin-2 receptor antagonists
BR112014015482A2 (en) phenyl carbamate compounds for use in the alleviation or treatment of pain and neuropathic pain
JP2012131811A5 (en)
RU2011125640A (en) EYE DROPS WITH DIFLUOPREDNAT FOR THE TREATMENT OF YELLOW SPOT
BR112012033738A2 (en) Method for treating bipolar disorder
FR3034993B1 (en) UNIT PACKAGING, COMPOSITIONS AND THERAPEUTIC DIAGRAMS FOR THE ADMINISTRATION OF PRO-RESOLUTION PATHWAY STIMULATORS ON KERATINIC SURFACES
HRP20220277T1 (en) Treatment of fragile x syndrome and autism with cannabidiol
AR092719A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF ECTOPARASITES
CN105748790A (en) Chinese herbal medicine powder used for expelling parasites of cattle and sheep
MD20140004A2 (en) Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
AR093908A1 (en) FUSION OF HUMAN AND ALBUMINE GROWTH HORMONE, FORMULATION AND USES OF THE SAME
AR088204A1 (en) MEDICINES FOR THE TREATMENT OF ALLERGY RHINITIS THAT INCLUDE A PGD2 ANTAGONIST AND A HISTAMINE ANTAGONIST
HRP20230300T1 (en) Combinations of imetelstat and venetoclax for the treatment of acute myeloid leukaemia
AR098832A1 (en) USE OF LAQUINIMOD TO DELAY THE PROGRESSION OF HUNTINGTON'S DISEASE
CO2020001887A2 (en) Synergistic pharmaceutical combination of the active enantiomer s-ketorolac and gabapentin for the treatment of neuropathic pain
EA201591603A1 (en) NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES
TN2016000179A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor.

Legal Events

Date Code Title Description
FB Suspension of granting procedure